CCL5 and Familial prostate cancer: Overall, this study not only revealed the underlying mechanisms by which TAMs promoted PCSCs but also uncovered TAMs/CCL5 as a novel target in predicting prostate cancer prognosis and inhibiting prostate cancer metastasis.